During the last session, Equillium Inc (NASDAQ:EQ)’s traded shares were 1.31 million, with the beta value of the company hitting 1.64. At the end of the trading day, the stock’s price was $0.49, reflecting an intraday loss of -35.62% or -$0.27. The company’s market capitalization is $17.29M, and the average intraday trading volume over the past 10 days was 0.18 million shares, and the average trade volume was 805.12K shares over the past three months.
Equillium Inc (EQ) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. EQ has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
Equillium Inc (NASDAQ:EQ) trade information
Equillium Inc (EQ) registered a -35.62% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -35.62% in intraday trading to $0.49, hitting a weekly high. The stock’s 5-day price performance is -39.00%, and it has moved by -36.21% in 30 days. Based on these gigs, the overall price performance for the year is -80.00%. The short interest in Equillium Inc (NASDAQ:EQ) is 0.36 million shares and it means that shorts have 4.02 day(s) to cover.
Equillium Inc (EQ) estimates and forecasts
In the rating firms’ projections, revenue will decrease -100.00% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 18.79%. While earnings are projected to return -273.91% in 2025.
EQ Dividends
Equillium Inc is due to release its next quarterly earnings on 2025-Mar-26. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Equillium Inc (NASDAQ:EQ)’s Major holders
Equillium Inc insiders own 36.15% of total outstanding shares while institutional holders control 19.42%, with the float percentage being 30.42%. DECHENG CAPITAL LLC is the largest shareholder of the company, while 26.0 institutions own stock in it. As of 2024-06-30, the company held over 4.45 million shares (or 12.6148% of all shares), a total value of $3.08 million in shares.
The next largest institutional holding, with 1.82 million shares, is of TAKEDA PHARMACEUTICAL CO LTD’s that is approximately 5.1711% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.26 million.
